2012 International Microbicides Conference Planning Committee
|
Meeting/ Workshop
|
CDC, FDA
|
NIAID, NICHD, NIMH, OD
|
2009
|
|
A Re-Emerging Challenge: New Opportunities for Dengue Research Collaboration
|
Meeting/ Workshop
|
CDC, FDA
|
NIAID
|
2011
|
|
Accelerating Therapies for Rare Diseases Workshop
|
Meeting/ Workshop
|
FDA
|
NINDS, OD
|
2010
|
|
Adolescent Health Working Group
|
Committee/ Workgroup
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NICHD, NIDA, NIMH, NIMHD
|
2010
|
|
Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me)
|
Research Initiative
|
FDA
|
CC, NCCAM, NHLBI, NIAMS, NICHD
|
2005
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee/ Workgroup
|
FDA, OS
|
NIAID, NINDS
|
2011
|
|
Advancing Regulatory Science Through Novel Research and Science-Based Technologies
|
Research Initiative
|
FDA
|
NIDDK, NINDS, OD
|
2010
|
|
Advising on Human Papillomavirus (HPV) Tests
|
Other
|
FDA
|
NCI
|
2008
|
|
Advisory Committee on HIV and STD Prevention and Treatment
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
OD
|
2003
|
|
AIDSinfo/InfoSIDA
|
Information Clearinghouse
|
CDC, CMS, FDA, HRSA
|
NIAID, NLM, OD
|
2002
|
|
Air Force Medical Service CTSA Collaboration Workshop: Opportunities in Translational Science Research
|
Meeting/ Workshop
|
AHRQ, FDA, HRSA
|
CC, NCI, NCATS, NHGRI, NIAID, NIBIB, NICHD, NIDDK, NLM, OD
|
2009
|
|
Alcohol Clinical Trial Initiative (ACTIVE)
|
Committee/ Workgroup
|
FDA
|
NIAAA, NIDA
|
2007
|
|
Alzheimer's Disease Neuroimaging Initiative
|
Research Initiative
|
FDA
|
NIA, NIBIB
|
2004
|
|
American Association of Blood Banks (AABB) Interorganizational Biovigilance Network Task Force
|
Committee/ Workgroup
|
CDC, FDA
|
NHLBI
|
2006
|
|
American Conference for the Treatment of HIV (ACTHIV)
|
Committee/ Workgroup
|
CDC, FDA, HRSA
|
NCI, NICHD, NIDA, NIMH, OD
|
2004
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks
|
Committee/ Workgroup
|
FDA
|
NCI, NCATS, NINDS
|
2011
|
|
Anti-Infective Drugs Advisory Committee
|
Committee/ Workgroup
|
FDA
|
NIAID
|
2007
|
|
Antiretroviral Pregnancy Registry
|
Committee/ Workgroup
|
CDC, FDA
|
NICHD
|
1989
|
|
Assessment of Validities for Analytical Protocols & Prototypes for Various Dietary Supplements (AOAC)
|
Research Initiative
|
FDA
|
OD
|
2004
|
|
Asthma Outcomes Workshop
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, FDA, HRSA
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
2009
|
|
Autoimmune Disease Coordinating Committee
|
Committee/ Workgroup
|
CDC, FDA, HRSA
|
CSR, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, OD
|
2002
|
|
Bacterial Waterborne and Emerging Infectious Diseases in the MENA Region
|
Meeting/ Workshop
|
CDC, FDA
|
NIAID
|
2011
|
|
Bench-to-Bedside (B2B) Program
|
Research Initiative
|
FDA
|
CC, NCI, NCATS, NHGRI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIGMS, NIMH, NIMHD, NINDS, NINR, OD
|
2009
|
|
Best Pharmaceuticals for Children Act
|
Research Initiative
|
FDA
|
NHLBI, NICHD, NIMH, OD
|
2002
|
|
caBIG® Integrative Cancer Research Nanotechnology Working Group
|
Committee/ Workgroup
|
FDA
|
NCI, NIBIB
|
2007
|
|
caNanoLab
|
Database
|
FDA
|
NCI, NIBIB, NIEHS
|
2007
|
|
Children's Environmental Health Task Force Chemical Exposures Workgroup
|
Committee/ Workgroup
|
ATSDR, CDC, FDA, OS
|
NIAID, NICHD
|
2010
|
|
Chronic Fatigue Syndrome Advisory Committee (CFSAC)
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, HRSA, OS
|
NCCAM, NCI, NCATS, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, OD
|
2003
|
|
Chronic Toxicity Test for Bisphenol A
|
Research Initiative
|
FDA
|
NIEHS
|
2011
|
|
Clinical and Translational Science Awards (CTSA) Education and Career Development Key Function Committee
|
Committee/ Workgroup
|
FDA
|
CC, NCCAM, NCI, NCATS, NHLBI, NIAAA, NIDCR, NIDDK, NIMH, NINR
|
2009
|
|
Clinical and Translational Science Awards (CTSA) Regulatory Knowledge Key Function Committee
|
Committee/ Workgroup
|
FDA
|
CC, NCI, NCATS, NHGRI, NIAID, NIBIB, NICHD, NIDDK, NLM, OD
|
2008
|
|
Clinical Data Acquisition Standards Harmonization (CDASH) Initiative led by Clinical Data Interchange Standards Consortium (CDISC)
|
Committee/ Workgroup
|
FDA
|
NCI
|
2006
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee/ Workgroup
|
CDC, FDA
|
NIAID
|
2009
|
|
Clinical Islet Transplantation Consortium
|
Research Initiative
|
CMS, FDA
|
NIAID
|
2004
|
|
Collaborative Islet Transplant Registry Ad Hoc Scientific Advisory Committee
|
Committee/ Workgroup
|
FDA, HRSA
|
NIAID, NIDDK
|
2009
|
|
Comparative Effectiveness Research Committee
|
Committee/ Workgroup
|
AHRQ, CMS, FDA
|
CC, NCCAM, NCI, NCATS, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
2008
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2002
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC
|
2004
|
|
Conducting Comprehensive Toxicological Assessments
|
Research Initiative
|
FDA
|
NIEHS
|
Unknown
|
|
Coordinating Committee on Women's Health (CCWH)
|
Committee/ Workgroup
|
ACF, AoA, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
OD
|
1990
|
|
Council on Emergency Medical Care
|
Committee/ Workgroup
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCATS, NHLBI, NICHD, NIGMS, NIMH, NINDS
|
2008
|
|
Countermeasures Against Chemical Threats (CounterACT) Research Network Annual Symposium
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS, OD
|
2006
|
|
Creutzfeldt-Jakob Disease Surveillance in Recipients of Human Growth Hormone, National Hormone and Pituitary Program (NHPP)
|
Disease Registry
|
CDC, FDA
|
NIDDK
|
1985
|
|
DailyMed
|
Other
|
FDA
|
NLM
|
2005
|
|
Data Mining on FDA's 510K Documents for Laboratory Tests
|
Research Initiative
|
FDA
|
NLM
|
2009
|
|
Demand Reduction Interagency Working Groups
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA
|
2009
|
|
Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A
|
Research Initiative
|
FDA
|
NIAID, NINDS
|
2010
|
|
DHHS Behavioral Health Coordinating Committee Pharmaceutical Abuse Subcommittee Surveillance Report Team
|
Committee/ Workgroup
|
CDC, FDA, OS, SAMHSA
|
NIDA
|
2011
|
|
DHHS Childhood Overweight and Obesity Prevention Council
|
Public Education Campaign
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NIDDK
|
2008
|
|
DHHS Women's Health and the Environment Interagency Committee
|
Committee/ Workgroup
|
ATSDR, CDC, FDA, HRSA, IHS, OS
|
NCI, NICHD, OD
|
2000
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
CSR, NCCAM, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD
|
1974
|
|
Dietary Supplements Federal Workgroup
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, HRSA, SAMHSA
|
NCCAM, NCI, NCATS, NHLBI, NIDDK, NIEHS
|
2008
|
|
Dietary Supplements Ingredient Database (DSID)
|
Database
|
CDC, FDA
|
NCI, OD
|
2002
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
CC
|
2011
|
|
Domestic Scheduling to Control New Drugs of Abuse, with NIDA-Funded Testing Conducted in Support of Drug Enforcement Administration (DEA) Scheduling Recommendations to the FDA
|
Research Initiative
|
FDA, OS
|
NIDA
|
Unknown
|
|
Dominantly Inherited Alzheimer’s Network (DIAN): International Network for the Identification, Evaluation, and Follow up of Families with Early Onset Dominantly Inherited Alzheimer’s Disease
|
Research Initiative
|
FDA
|
NIA
|
2008
|
|
Drug Induced Liver Injury Network (DILIN)
|
Committee/ Workgroup
|
FDA
|
NIDDK
|
2003
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee/ Workgroup
|
FDA
|
NIAID
|
2003
|
|
Evaluation of Patient Reported Outcomes Following LASIK Surgery.
|
Research Initiative
|
FDA
|
NEI
|
2009
|
|
Evidence Based Review & Report Program
|
Committee/ Workgroup
|
AHRQ, FDA
|
NCCAM, OD
|
2001
|
|
Evidence Based Review - Probiotic Safety
|
Other
|
AHRQ, FDA
|
NCCAM, OD
|
2008
|
|
Family Smoking Prevention and Tobacco Control Act National Longitudinal Study
|
Research Initiative
|
FDA
|
NCI, NHLBI, NICHD, NIDA, NIEHS, OD
|
2010
|
|
FDA Blood Products Advisory Committee
|
Committee/ Workgroup
|
CDC, FDA
|
CC, NHLBI
|
2007
|
|
FDA Cancer Diagnosis Program (CDP) Monthly Meeting
|
Committee/ Workgroup
|
FDA
|
NCI
|
2010
|
|
FDA Center of Drug Evaluation and Research (CDER) Workgroup
|
Committee/ Workgroup
|
FDA
|
CC
|
2011
|
|
FDA Clinical Pharmacology Review Rotation
|
Training Initiative
|
FDA
|
CC
|
2005
|
|
FDA Substance Registry System Public Interface
|
Database
|
FDA
|
NLM
|
2009
|
|
FDA/Center for Biologics and Evaluation and Research (CBER) Genomic Biologics
|
Committee/ Workgroup
|
FDA
|
NIAID
|
2010
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, OS
|
NIDDK
|
2005
|
|
Federal HIV/AIDS Web Council (AIDS.gov)
|
Committee/ Workgroup
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NIAID, NIDA, NLM, OD
|
2006
|
|
Federal Interagency Traumatic Brain Injury Research (FITBIR) Working Group
|
Committee/ Workgroup
|
CDC, FDA, HRSA, OS, SAMHSA
|
NCATS, NHLBI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIGMS, NIMH, NINDS, OD
|
2008
|
|
Federal Interagency Working Group on Vitamin D
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, OS
|
NCCAM, NCI, NEI, NHLBI, NIA, NIAMS, NICHD, NIDDK, NIEHS, NIMHD, OD
|
Unknown
|
|
Federal Interagency Working Group on Women's Health and the Environment
|
Committee/ Workgroup
|
CDC, FDA
|
NCI, NIEHS
|
1994
|
|
Federal Investigator Registry of Biomedical Information Research (FIREBIRD)
|
Database
|
FDA
|
NCI
|
2004
|
|
Federal Liaison Group on Asthma (FLGA)
|
Committee/ Workgroup
|
ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIAID, NIEHS, NIMH, NINR, NLM
|
2003
|
|
Federal mHealth Collaborative
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NCI, NICHD, NIDA, OD
|
2011
|
|
Federal Partners in the Gulf Long-Term Follow-up (GuLF) Study Working Group
|
Committee/ Workgroup
|
ACF, ATSDR, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
CIT, NHGRI, NIEHS, NIMH, NLM, OD
|
2010
|
|
Federal Partners Senior Workgroup for Mental Health Transformation
|
Committee/ Workgroup
|
ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA
|
NIDA, NIMH
|
2008
|
|
Federal Working Group on Bone Diseases
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, OS
|
CSR, NCCAM, NCI, NCATS, NEI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDCR, NIDDK, NIEHS, NIMH, NINR, OD
|
1993
|
|
Federal Working Group on Dietary Supplements (FWGoDS)
|
Committee/ Workgroup
|
AoA, AHRQ, CDC, FDA
|
CC, CSR, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
2005
|
|
FedTel: Cross-Federal Work Group on Telehealth
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIBIB, NLM, OD
|
2011
|
|
Filovirus Animal Non-Clinical Group (FANG) Team Charter
|
Committee/ Workgroup
|
CDC, FDA
|
CC, NIAID
|
2011
|
|
Genetics/Genomics Research Coordinating Committee
|
Committee/ Workgroup
|
FDA
|
NCI, NCATS, NHGRI, NIAID, NICHD, NIDA, NIGMS, NIMH, OD
|
2011
|
|
Global Collaboration Call
|
Committee/ Workgroup
|
AoA, CDC, FDA, HRSA, SAMHSA
|
NIMH
|
Unknown
|
|
Global Health Initiative (GHI) Research Committee
|
Committee/ Workgroup
|
CDC, FDA, HRSA, OS
|
FIC, NIAID, NICHD, OD
|
2010
|
|
Glycomics/Glycoscience Needs
|
Meeting/ Workshop
|
FDA
|
NCI, NCATS, NHLBI, NIAID, NIDCR, NIGMS
|
2010
|
|
Glycosciences Research Day
|
Meeting/ Workshop
|
FDA
|
NIGMS
|
2008
|
|
Guidelines for Prevention and Treatment of HIV Related Opportunistic Infections in Adults and Adolescents
|
Other
|
CDC, FDA, HRSA
|
CC
|
1987
|
|
Guidelines for Prevention of Mother to Child HIV Transmission; Guidelines for Pediatric Antiretroviral Treatment; Guidelines for Adult Antiretroviral Treatment; Guidelines for Prevention and Treatment of Opportunistic Infections in Adults; Guidelines
|
Committee/ Workgroup
|
CDC, FDA, HRSA
|
NIAID, NICHD
|
1998
|
|
Gulf Oil Spill Interagency Coordination for Issues Involving Toxicology, Health Effects, and Research
|
Committee/ Workgroup
|
ATSDR, CDC, CMS, FDA, HRSA, OS, OSG
|
NIEHS, NIMH, NLM
|
2010
|
|
Health Literacy Work Group
|
Committee/ Workgroup
|
AoA, AHRQ, CDC, FDA, OS
|
NCI, NEI, NHGRI, NHLBI, NIA, NIBIB, NICHD, NIDA, NIDCR, NIEHS, NIMH, NINR, NLM, OD
|
2007
|
|
Health Maintenance Organizations (HMO) Collaboratory
|
Research Initiative
|
AHRQ, CDC, FDA
|
NCCAM, NCI, NCATS, NHGRI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, OD
|
2011
|
|
Healthy People 2010 - Kidney Disease
|
Public Education Campaign
|
CDC, CMS, FDA, HRSA, OS
|
NIDDK
|
1998
|
|
Healthy People 2020
|
Committee/ Workgroup
|
AHRQ, ATSDR, CDC, FDA, HRSA, OS
|
NCI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
2008
|
|
Healthy People 2020 - Blood Diseases, Disorders, and Safety
|
Committee/ Workgroup
|
CDC, FDA, HRSA, OS
|
NHLBI
|
2006
|
|
Healthy People 2020 Federal Interagency Special (LGBT) Populations Workgroup
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, HRSA, OS, SAMHSA
|
OD
|
2010
|
|
Hemoglobinopathy Uniform Medical Language Ontology Project
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, HRSA, OS
|
NHLBI, NIAMS, NICHD, NLM, OD
|
2008
|
|
HHS Advisory Committee for the Elimination of Tuberculosis
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NIAID
|
2009
|
|
HHS Behavioral Health Coordinating Committee
|
Committee/ Workgroup
|
ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA, NIMH
|
2009
|
|
HHS Biomedical Advanced Research and Development Authority (BARDA) Acute Radiation Syndrome Dosimetry Working Group
|
Committee/ Workgroup
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
HHS Biomedical Advanced Research and Development Authority (BARDA) Radiological/ Nuclear Integrated Program Team
|
Committee/ Workgroup
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
HHS Biomedical Advanced Research and Development Authority (BARDA) Radiological/Nuclear Working Group on Blood and Tissue Products
|
Committee/ Workgroup
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
HHS Biovigilance Committee
|
Committee/ Workgroup
|
CDC, CMS, FDA, HRSA, OS
|
CC, NHLBI
|
2009
|
|
HHS Blood Safety Committee
|
Committee/ Workgroup
|
CDC, FDA
|
NHLBI
|
1997
|
|
HHS Blood, Organ, and Tissue Safety Committee (BOTSEC)
|
Committee/ Workgroup
|
CDC, CMS, FDA, HRSA, OS
|
CC, NHLBI
|
1997
|
|
HHS Data Council
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIA, NIMH
|
2005
|
|
HHS Dietary Guidance Review Committee
|
Committee/ Workgroup
|
ACF, AoA, CDC, FDA, HRSA, IHS, OS
|
NIDDK
|
1990
|
|
HHS Federal Partners Sickle Cell Disease Initiative
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NHLBI
|
2009
|
|
HHS Health Literacy Working Group
|
Committee/ Workgroup
|
ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NCI, NEI, NLM, OD
|
2006
|
|
HHS HIV/AIDS Management Team
|
Committee/ Workgroup
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
OD
|
1982
|
|
HHS Lyme and Tick Borne Diseases
|
Committee/ Workgroup
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
HHS Nutrition Policy Board
|
Committee/ Workgroup
|
ACF, AoA, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NIDDK
|
1986
|
|
HHS Outreach and Messaging Working Group, Part of the HHS Steering Committee for the Prevention of Healthcare-Associated Infections
|
Committee/ Workgroup
|
ACF, AoA, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
CC, NIAID, OD
|
2008
|
|
HHS Viral Hepatitis Interagency Working Group
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NIAID
|
2009
|
|
Human Nutrition Research Information Management (HNRIM) System
|
Information Clearinghouse
|
CDC, FDA, HRSA
|
NIDDK
|
1985
|
|
Image-Guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI, NIAID, NIBIB
|
2004
|
|
Image-Guided Tumor Targeted Delivery (IGTD) in Cancer
|
Committee/ Workgroup
|
FDA
|
NCI
|
2010
|
|
Improving Technical Standards and Molecular Tools for Probiotics Research and Development
|
Research Initiative
|
FDA
|
NCCAM
|
2008
|
|
Influenza Vaccine Manufacturing Improvement Initiative
|
Committee/ Workgroup
|
CDC, FDA
|
NIAID
|
2010
|
|
Interagency Animal Management Committee
|
Committee/ Workgroup
|
CDC, FDA
|
NCATS, NHLBI, NIAID, NIMHD
|
1987
|
|
Interagency Artificial Pancreas Working Group
|
Committee/ Workgroup
|
FDA
|
NIBIB, NICHD
|
2007
|
|
Interagency Chemical Hazards Working Group
|
Committee/ Workgroup
|
CDC, FDA, OS
|
NINDS
|
2007
|
|
Interagency Collaborative to Advance Research in Epilepsy (ICARE)
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, HRSA
|
FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDA, NIGMS, NIMH, NINDS, NINR, OD
|
2003
|
|
Interagency Committee on Drug Control (ICDC)
|
Committee/ Workgroup
|
FDA, OS, SAMHSA
|
NIDA
|
1981
|
|
Interagency Committee on Emergency Medical Services for Children Research (ICER)
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, HRSA, OS, SAMHSA
|
NHLBI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt-Jakob Disease
|
Committee/ Workgroup
|
CDC, FDA
|
NICHD, NIDDK, NINDS
|
1984
|
|
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)
|
Research Initiative
|
ATSDR, CDC, FDA
|
NCI, NEI, NIAID, NIEHS, NLM, OD
|
2000
|
|
Interagency Council on Biomedical Imaging in Oncology (ICBIO)
|
Meeting/ Workshop
|
AHRQ, CMS, FDA
|
NCI
|
1999
|
|
Interagency Group on Alzheimer's Disease and Related Dementias for implementation of the National Alzheimer's Project Act
|
Committee/ Workgroup
|
AoA, AHRQ, CDC, CMS, FDA, HRSA
|
NIA
|
2011
|
|
Interagency Midazolam Product Coordination Team
|
Committee/ Workgroup
|
FDA, OS
|
NIAID, NINDS
|
2011
|
|
Interagency Modeling and Analysis Group
|
Committee/ Workgroup
|
FDA
|
CSR, FIC, NCI, NCATS, NHGRI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD
|
2003
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee/ Workgroup
|
AHRQ, CDC, FDA
|
NIDCR, NINDS
|
2011
|
|
Interagency Subcommittee on Disability Statistics (ISDS)
|
Committee/ Workgroup
|
ACF, AoA, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDCD
|
1996
|
|
Interagency Working Group in Preparation for the Annual U.N. Commission on Narcotic Drugs Meeting
|
Committee/ Workgroup
|
FDA, OS, SAMHSA
|
NIDA
|
Unknown
|
|
Interagency Working Group on Hematopoietic Stem Cells
|
Committee/ Workgroup
|
CMS, FDA, HRSA
|
NIAID
|
2009
|
|
Interagency Working Group on Human Stem Cell Transplantation
|
Information Clearinghouse
|
CDC, FDA, HRSA
|
NHLBI
|
1998
|
|
Interagency Working Group to Develop White House National HIV/AIDS Strategy
|
Committee/ Workgroup
|
ACF, AoA, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIAID, NIDA, NIMH, OD
|
2009
|
|
INTERMACS - Interagency Registry for Mechanically Assisted Circulatory Support
|
Disease Registry
|
CMS, FDA
|
NHLBI
|
2005
|
|
International Experience and Technical Assistance Training Program (IETA)
|
Training Initiative
|
CDC, FDA, HRSA
|
NIMH
|
1997
|
|
International TB Working Group
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, IHS, OS
|
FIC, NHLBI, NIAID, NICHD, NIDA
|
2003
|
|
JANUS
|
Database
|
FDA
|
NCI
|
2005
|
|
Joint Committee and Joint Commission Meetings
|
Committee/ Workgroup
|
CDC, FDA, OS
|
FIC, NCI, NIAID
|
2011
|
|
Joint Fellowship Program
|
Training Initiative
|
FDA
|
NCI
|
2005
|
|
Kidney Interagency Coordinating Committee (KICC)
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NHLBI
|
Unknown
|
|
Kidney, Urologic, and Hematologic Diseases Interagency Coordinating Committee (KUHICC)
|
Committee/ Workgroup
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS
|
CSR, NCI, NCATS, NHLBI, NIA, NIAID, NIAMS, NIDDK, NINR
|
1987
|
|
Lesbians, Gay, Bisexuals, and Transgender (LGBT) Coordinating Committee
|
Committee/ Workgroup
|
ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NICHD, OD
|
2010
|
|
Lupus Federal Working Group
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, HRSA, OS
|
NCCAM, NEI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIMHD, NINDS, OD
|
2003
|
|
Lyme Disease Coordinating Committee
|
Committee/ Workgroup
|
CDC, FDA
|
FIC, NCATS, NIA, NIAID, NIAMS, NIMH, NINDS
|
2007
|
|
Memorandum of Understanding (MOU) Between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH
|
Other
|
FDA
|
NINDS
|
2002
|
|
Meta-Analysis of the Risk of Guillain-Barre Syndrome Following H1N1 Vaccination
|
Committee/ Workgroup
|
FDA
|
NIAID
|
2011
|
|
Methylphenidate in Male Rhesus Monkeys
|
Research Initiative
|
FDA
|
NICHD
|
2008
|
|
mHealth (Mobile Health Technologies) Evidence meeting
|
Meeting/ Workshop
|
CMS, FDA, HRSA
|
NHLBI, NICHD, OD
|
2011
|
|
mHealth (Mobile Health Technologies) Summit 2011
|
Meeting/ Workshop
|
FDA, OS, OSG
|
FIC, NCI, NHLBI, NIBIB, NICHD, NIDA, NIDDK, NIEHS, NINDS, NLM, OD
|
2009
|
|
Microbicide Trials Network Executive Committee
|
Committee/ Workgroup
|
FDA
|
NIAID, NICHD, NIMH, OD
|
2006
|
|
Microsystems Team
|
Committee/ Workgroup
|
FDA
|
NINDS, OD
|
2011
|
|
Million Hearts
|
Committee/ Workgroup
|
AoA, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA
|
NHLBI, NINDS
|
2010
|
|
Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group
|
Committee/ Workgroup
|
CMS, FDA
|
NHLBI, NIAMS, NIBIB, NICHD, NIDCD, NIDCR
|
2000
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Committee/ Workgroup
|
ACF, CDC, FDA, HRSA
|
NHLBI, NIAMS, NICHD, NINDS
|
2001
|
|
Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
National Academies Workshop: Emerging Technologies for Measuring Individual Exposomes
|
Meeting/ Workshop
|
ATSDR, CDC, FDA
|
NICHD, NIEHS, OD
|
2011
|
|
National Asthma Control Initiative/National Asthma Education and Prevention Program
|
Committee/ Workgroup
|
CDC, FDA
|
NHLBI, NIAID, NIEHS
|
2008
|
|
National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA)
|
Committee/ Workgroup
|
AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
1998
|
|
National Health and Nutrition Examination Survey (NHANES)
|
Health Survey
|
ACF, CDC, FDA, OS
|
NCI, NHLBI, NIA, NIDDK, OD
|
1997
|
|
National Kidney Disease Education Program
|
Public Education Campaign
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NHLBI
|
1998
|
|
National Obesity Action Forum and Other Follow up Meetings to the Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity
|
Committee/ Workgroup
|
AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NIDDK
|
2001
|
|
National Partnership for Action to End Health Disparities (NPA): Federal Interagency Health Equity Team (FIHET)
|
Committee/ Workgroup
|
ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCI, NCATS, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR, OD
|
2006
|
|
National Prevention Strategy
|
Committee/ Workgroup
|
AoA, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCI, NHLBI, NIDDK, OD
|
2010
|
|
National Robotics Initiative
|
Research Initiative
|
FDA
|
NCATS, NIA, NIBIB, NICHD, NINDS, NINR
|
2009
|
|
National Science Advisory Board for Biosecurity (NSABB)
|
Committee/ Workgroup
|
CDC, FDA, OS
|
NIAID
|
2004
|
|
National Women's Health Week
|
Other
|
ACF, AoA, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA
|
CC, CIT, CSR, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
2005
|
|
NEI/FDA Endpoints Symposium: Use of Functional Vision Endpoints in Visual Prostheses Product Development
|
Meeting/ Workshop
|
FDA
|
NEI
|
2008
|
|
Network for Translational Research (NTR): Optical Imaging in Multimodality Platforms
|
Research Initiative
|
FDA
|
NCI
|
2009
|
|
Neural Interfaces Conference
|
Meeting/ Workshop
|
FDA
|
CSR, NEI, NIA, NIBIB, NICHD, NIDCD, NINDS, OD
|
2006
|
|
NIDA Consultative Assistance to the FDA Regarding Domestic Scheduling of New Medications
|
Other
|
FDA
|
NIDA
|
Unknown
|
|
NIH American Association for Clinical Chemistry (AACC) Statistics and Experimental Design Workshop
|
Meeting/ Workshop
|
FDA
|
NCI, NHLBI
|
2011
|
|
NIH Recombinant DNA Advisory Committee
|
Committee/ Workgroup
|
CDC, FDA, OS
|
NCI, NHGRI, NIAID, NINDS
|
1974
|
|
NIH Translational Research Interest Group
|
Committee/ Workgroup
|
FDA
|
CC, CIT, CSR, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
2008
|
|
NIH/FDA Interagency Clinical Outcome Assessments Working Group
|
Committee/ Workgroup
|
FDA
|
CC, NCCAM, NCI, NHLBI, NIA, NIAMS, NICHD, NIDDK, NIMH, NINDS, OD
|
2010
|
|
NIH/FDA Joint Leadership Council
|
Committee/ Workgroup
|
FDA
|
NCI, NHLBI, NIAID, NIDDK, NIGMS, NIMH, NINDS, OD
|
2010
|
|
NIH/FDA Leadership Council Working Group Drug Rescue & Repurposing Committee
|
Committee/ Workgroup
|
FDA
|
NIAID, OD
|
2011
|
|
NIH/FDA Tobacco Science Working Group
|
Committee/ Workgroup
|
FDA
|
NCI, NIGMS
|
2011
|
|
Nutrition Coordinating Committee (NCC)
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, HRSA, IHS, OS
|
CC, CIT, CSR, FIC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
1975
|
|
PACT (Production Assistance for Cellular Therapies) Workshop - Cell Therapy for Pediatric Diseases: A Growing Frontier
|
Committee/ Workgroup
|
FDA
|
NHLBI
|
2011
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS)
|
Research Initiative
|
FDA
|
NCCAM, NCI, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIGMS, NIMH, NINDS, OD
|
2004
|
|
Pediatric Formulations Platform
|
Committee/ Workgroup
|
FDA
|
NICHD, NINR
|
2010
|
|
Peripheral and Central Nervous System Drugs Advisory Committee
|
Committee/ Workgroup
|
FDA
|
CC
|
2009
|
|
Personal Motion Technologies for Healthy Independent Living
|
Meeting/ Workshop
|
CMS, FDA
|
NCATS, NIA, NIBIB, NICHD, NINDS, OD
|
2010
|
|
Phenylketonuria (PKU) Scientific Workshop
|
Meeting/ Workshop
|
AHRQ, FDA, HRSA
|
NHGRI, NICHD, NIDDK, NINDS, NINR, OD
|
2010
|
|
Pillbox
|
Database
|
FDA
|
NLM
|
2009
|
|
Planning Committee to Outline Guidelines for the Conduct of Biomedical Prevention Intervention Research During Pregnancy
|
Committee/ Workgroup
|
CDC, FDA
|
NIAID, NICHD, OD
|
2011
|
|
Pluripotent Stem Cells in Translation: Early Decisions
|
Meeting/ Workshop
|
FDA
|
CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NINDS, OD
|
2009
|
|
Procurement of Biotechnology Services, Including GFP Cell Sorting and Analysis
|
Research Initiative
|
FDA
|
NICHD
|
2009
|
|
Proteomics (NCI/FDA Memorandum of Understanding)
|
Research Initiative
|
FDA
|
NCI
|
2006
|
|
Public Health Dimensions of Epilepsy
|
Other
|
ACF, CDC, FDA, OS
|
NIA, NICHD, NIMH, NINDS
|
2010
|
|
Public Health Emergency Management Countermeasures Enterprise (PHEMCE)
|
Committee/ Workgroup
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2008
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Requirements Working Group
|
Committee/ Workgroup
|
CDC, FDA, OS
|
NIAID, NICHD, NIEHS, NINDS
|
2007
|
|
Public Health Service (PHS) Biovigilance Working Group
|
Committee/ Workgroup
|
CDC, FDA
|
NHLBI
|
1997
|
|
Public Health Service (PHS) Blood XMRV Scientific Research Working Group
|
Committee/ Workgroup
|
CDC, FDA
|
NHLBI
|
2000
|
|
Public Health Service (PHS) MSM Working Group
|
Committee/ Workgroup
|
CDC, FDA
|
NHLBI
|
2008
|
|
Public Health Service (PHS) Pathogen Reduction Taskforce
|
Committee/ Workgroup
|
CDC, FDA
|
NHLBI
|
2006
|
|
Quality Review of ClinicalTrials.gov
|
Database
|
AHRQ, FDA
|
CC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
2000
|
|
Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center
|
Training Initiative
|
FDA
|
CC, NCI, NIAID
|
2007
|
|
Research on the Comparative Management of Uterine Fibroid Disease
|
Committee/ Workgroup
|
AHRQ, CDC, FDA
|
NCCAM, NICHD, NIEHS, OD
|
2009
|
|
RxNorm
|
Other
|
FDA
|
NLM
|
2005
|
|
Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NIAID, NLM, OD
|
2009
|
|
Safety Reporting Portal
|
Database
|
FDA
|
OD/ OSP
|
2008
|
|
Scientific Advisory Committee on Alternative Toxicological Methods (SACATM)
|
Committee/ Workgroup
|
ATSDR, CDC, FDA
|
NCI, NIEHS, NLM, OD
|
1994
|
|
Secretary's Committee on Blood Safety and Availability (BSAC)
|
Committee/ Workgroup
|
CDC, CMS, FDA, OS
|
CC, NHLBI
|
2003
|
|
SNOMED (Systematized Nomenclature of Medicine) International and Support Services
|
Other
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NLM
|
2003
|
|
Specialized Centers of Research (SCOR) on Sex and Gender Factors Affecting Women's Health
|
Research Initiative
|
FDA
|
NIAMS, NICHD, NIDA, NIDDK, NIMH, OD
|
2002
|
|
Subcommittee on Nanoscale Science, Engineering, and Technology
|
Committee/ Workgroup
|
CDC, FDA
|
NCI, NHGRI, NIBIB, OD
|
2001
|
|
Subpopulations and Intermediate Outcome Measures in Chronic Obstructive Pulmonary Disease (COPD)
|
Research Initiative
|
FDA
|
NHLBI
|
2006
|
|
Surgeon General's Call to Action to Prevent Prescription Drug Abuse in Youth: The Dangers of Improper Use of Controlled Medications
|
Public Education Campaign
|
CDC, FDA, OS, OSG, SAMHSA
|
NIAAA, NIDA
|
2011
|
|
Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities
|
Committee/ Workgroup
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, OSG
|
NHLBI, NIAID, NICHD, NIEHS, NIMHD, NINR
|
2011
|
|
Terminology Resources
|
Database
|
FDA
|
NCI
|
2004
|
|
Text 4 Baby Program Evaluation Technical Advisory Group
|
Committee/ Workgroup
|
CDC, FDA, HRSA, OS, SAMHSA
|
NICHD
|
2010
|
|
The Federal TB Task Force
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
FIC, NCATS, NHLBI, NIAAA, NIAID, NICHD, NIDA
|
1991
|
|
The Foundation for the NIH Biomarkers Consortium
|
Committee/ Workgroup
|
CMS, FDA
|
NCI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIMH, NINDS, OD
|
2006
|
|
The Genetic and Rare Diseases Information Center
|
Information Clearinghouse
|
FDA, HRSA
|
NHGRI, NLM
|
2001
|
|
The Health Consequences of Smoking and Involuntary Exposure to Tobacco Smoke: An Update – Workgroup on Mathematical and Statistical Modeling on the Population Impact of Smoking
|
Committee/ Workgroup
|
CDC, FDA, OSG
|
NCI, NIGMS, OD
|
2010
|
|
The NIH Bone Marrow Stromal Cell Transplantation Center
|
Research Initiative
|
FDA
|
CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NINDS
|
2009
|
|
The Pharmacology Research Associate (PRAT) Program
|
Training Initiative
|
FDA
|
NIGMS
|
1965
|
|
The Science of Sex and Gender in Human Health
|
Other
|
FDA
|
OD
|
2006
|
|
The Trans-NIH Rare Diseases Working Group
|
Committee/ Workgroup
|
FDA
|
CC, CSR, FIC, NCCAM, NCI, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
2004
|
|
Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group
|
Committee/ Workgroup
|
FDA
|
NHGRI, OD
|
2009
|
|
Tobacco Control Strategic Planning Committee
|
Committee/ Workgroup
|
CDC, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCI, NIDA
|
2010
|
|
Tox21 Collaboration
|
Research Initiative
|
FDA
|
NHGRI, NIEHS
|
2006
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee/ Workgroup
|
CDC, FDA, OS
|
NIAID
|
2009
|
|
Trans-NIH Nanotechnology Task Force: National Nanotechnology Initiative (NNI) Call For Trans-agency Signature Initiatives
|
Committee/ Workgroup
|
FDA
|
NHLBI, NIBIB, NIDCD, NIDCR
|
2001
|
|
Trans-NIH Plan for HIV-Related Research
|
Committee/ Workgroup
|
CDC, FDA, OS
|
CC, CSR, FIC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD
|
1994
|
|
Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC)
|
Committee/ Workgroup
|
FDA
|
NIAID
|
2010
|
|
U. S. Government Interagency Working Group on Nanotechnology, Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC)
|
Committee/ Workgroup
|
CDC, FDA
|
NCI, NHGRI, NIBIB, NIEHS
|
2005
|
|
U.S. Government Microbicides Coordinating Committee
|
Committee/ Workgroup
|
CDC, FDA
|
FIC, NCI, NIAID, NICHD, NIDA, NIMH, NINR, OD
|
2001
|
|
U.S.-Brazil Working Group on Public Health
|
Committee/ Workgroup
|
CDC, FDA, OS
|
FIC, NCI, NIAID
|
2006
|
|
Unified Medical Language System Metathesaurus (UMLS)
|
Other
|
AHRQ, CDC, CMS, FDA
|
NLM
|
1990
|
|
Working Groups to Develop Federal HIV/AIDS Prevention and Treatment Guidelines
|
Committee/ Workgroup
|
CDC, FDA, HRSA
|
CC, NIAID, NICHD, NIMH, NLM, OD
|
2005
|
|
Workshop on Computer Models of Medical Devices
|
Meeting/ Workshop
|
FDA
|
NHLBI
|
2009
|
|
|